Quantum computing director Michael Turmelle sells $2.85m in stock

Published 12/06/2025, 00:54
Quantum computing director Michael Turmelle sells $2.85m in stock

Michael Turmelle, a director at Quantum Computing Inc. (NASDAQ:QUBT), recently executed a significant stock sale, according to an SEC filing. On June 9, Turmelle sold 200,986 shares of common stock at a price of $14.18 per share, totaling approximately $2.85 million. The stock, which has shown significant volatility with a beta of 3.85, has since risen to $18.96, delivering a remarkable 196% return over the past six months. InvestingPro data reveals 17 additional key insights about QUBT’s performance and outlook.

Prior to this sale, on June 3, Turmelle acquired 200,986 shares through the exercise of stock options, with a total value of $478,744, at prices ranging from $2.37 to $2.40 per share. Following these transactions, Turmelle no longer holds any directly owned shares, although he retains options to purchase an additional 400,000 shares. The company, now valued at $2.7 billion, maintains strong liquidity with a current ratio of 44.69. Get the complete financial analysis with a detailed InvestingPro Research Report.

In other recent news, Quantum Computing Inc. reported a surprising earnings performance for Q1 2025, with an earnings per share (EPS) of 11 cents, significantly outperforming the forecasted loss of 5 cents. Despite this, the company’s revenue fell short of expectations, reaching only $39,000 compared to the projected $300,000. The company also announced its inclusion in the Russell 3000 and Russell 2000 indexes, which is expected to enhance its visibility among institutional investors. Quantum Computing Inc. raised $93.6 million through stock offerings in the first quarter, bolstering its cash and cash equivalents to $166.4 million. The company’s total assets grew to $242.5 million, up from $153.6 million at the end of 2024. Additionally, Quantum Computing Inc. has been expanding its strategic collaborations, including a partnership with the Sandoz (SIX:SDZ) Ture Institutional Therapeutics Discovery (NASDAQ:WBD) Institute. The firm is also planning to expand its operations with a second fabrication facility to meet the growing demand for its quantum computing applications. Analyst feedback from firms like Ascenient Capital suggests a positive outlook, with expectations of accelerated growth in 2026.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.